The N-terminal non-RGS domain of human regulator of G-protein signalling 1 contributes to its ability to inhibit pheromone receptor signalling in yeast

被引:8
|
作者
Somerville, W
Song, W
Kong, JL
Panetta, R
Greenwood, MT
机构
[1] McGill Univ, Dept Anat & Cell Biol, Polypeptide Lab, Montreal, PQ H3A 2B2, Canada
[2] McGill Univ, Ctr Hlth, Dept Med, Div Cardiol, Montreal, PQ, Canada
关键词
regulator of G-protein signalling (RGS); heterologous expression; G-protein coupled receptors; signal transcluction; GFP fusions;
D O I
10.1016/S0898-6568(02)00121-3
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Regulators of G-protein signalling (RGS) are a family of proteins that interact with G-proteins to regulate negatively G-protein coupled receptor (GPCR) signalling. In addition to a conserved core domain that is necessary and sufficient for their GTPase activating protein (GAP) like activity, RGSs possess N- and C-terminal motifs that confer distinct functional differences. In order to identify the role of the non-RGS region of human RGS1, we have characterized a series of fusions between RGS1 and GFP in a yeast mutant lacking the RGS containing SST2 gene. Using both halo assays as well as a GPCR responsive FUS1-LacZ reporter gene, we demonstrate that a RGS1-GFP fusion inhibits GPCR signalling in yeast while GFP fusions containing either the N-terminus non RGS sequence of RGS1(1-68) or the sequence containing the RGS box of RGS1(68-197) produce proteins that retain RGS1 activity. These results suggest that both the N-terminal and the RGS box of RGS I function to inhibit signalling. Analysis of a series of mutants spanning the entire N-terminal non-RGS region of RGS1 produced by conservative segment exchange (CSE) mutagenesis showed little loss of function in yeast. This suggests that the overall structure of the N-terminal region of RGS1 rather than specific motifs or residues is required for its function. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:413 / 421
页数:9
相关论文
共 50 条
  • [1] RGS3 interacts with 14-3-3 via the N-terminal region distinct from the RGS (regulator of G-protein signalling) domain
    Niu, JX
    Scheschonka, A
    Druey, KM
    Davis, A
    Reed, E
    Kolenko, V
    Bodnar, R
    Voyno-Yasenetskaya, T
    Du, XP
    Kehrl, J
    Dulin, NO
    BIOCHEMICAL JOURNAL, 2002, 365 : 677 - 684
  • [2] Evidence for the dimerization of human regulator of G-protein signalling 5 (RGS5)
    Yang, Zhao
    Gaudio, Sabrina
    Song, Wei
    Greenwood, Matthew
    Jean-Baptiste, Gaael
    Greenwood, Michael T.
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2007, 20 (05) : 303 - 310
  • [3] The RGS domain-containing fission yeast protein, Rgs1p, regulates pheromone signalling and is required for mating
    Pereira, PS
    Jones, NC
    GENES TO CELLS, 2001, 6 (09) : 789 - 802
  • [4] A new role for the regulator of G-protein signalling-1 (RGS-1) in the modulation of macrophage function in atherosclerosis
    Patel, J.
    McNeill, E.
    de Bono, J.
    Greaves, D.
    Channon, K.
    ATHEROSCLEROSIS, 2010, 213 (01) : E11 - E11
  • [5] Genetic or pharmacological inactivation of the dopamine D1 receptor differentially alters the expression of regulator of G-protein signalling (Rgs) transcripts
    Stanwood, Gregg D.
    Parlaman, Joshua P.
    Levitt, Pat
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2006, 24 (03) : 806 - 818
  • [6] The regulator of G-protein signalling Thn1 links pheromone response to volatile production in Schizophyllum commune
    Wirth, Sophia
    Kunert, Maritta
    Ahrens, Lisa-Marija
    Krause, Katrin
    Broska, Selina
    Paetz, Christian
    Kniemeyer, Olaf
    Jung, Elke-Martina
    Boland, Wilhelm
    Kothe, Erika
    ENVIRONMENTAL MICROBIOLOGY, 2018, 20 (10) : 3684 - 3699
  • [7] Roles of N-terminal subdomains of RGS2 in potent and selective inhibition of angiotensin AT1 receptor signalling
    Matsuzaki, Naoko
    Nishiyama, Mariko
    Song, Dan
    Moroi, Kayoko
    Kimura, Sadao
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2011, 115 : 272P - 272P
  • [8] Regulator of G-Protein Signalling 4 (RGS4) negatively modulates nociceptin/orphanin FQ opioid receptor signalling: Implication for l-Dopa-induced dyskinesia
    Pisano, Clarissa A.
    Mercatelli, Daniela
    Mazzocchi, Martina
    Brugnoli, Alberto
    Morella, Ilaria
    Fasano, Stefania
    Zaveri, Nurulain T.
    Brambilla, Riccardo
    O'Keeffe, Gerard W.
    Neubig, Richard R.
    Morari, Michele
    BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 (07) : 927 - 942
  • [9] The N-terminal domain of RGS4 confers receptor-selective inhibition of G protein signaling
    Zeng, WZ
    Xu, X
    Popov, S
    Mukhopadhyay, S
    Chidiac, P
    Swistok, J
    Danho, W
    Yagaloff, KA
    Fisher, SL
    Ross, EM
    Muallem, S
    Wilkie, TM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (52) : 34687 - 34690
  • [10] Inhibition of the regulator of G protein signalling RGS4 in the spinal cord decreases neuropathic hyperalgesia and restores cannabinoid CB1 receptor signalling
    Bosier, Barbara
    Doyen, Pierre J.
    Brolet, Amandine
    Muccioli, Giulio G.
    Ahmed, Eman
    Desmet, Nathalie
    Hermans, Emmanuel
    Deumens, Ronald
    BRITISH JOURNAL OF PHARMACOLOGY, 2015, 172 (22) : 5333 - 5346